Renger John

Renger John is listed in filings as Chief Scientific Officer at Cerevel Therapeutics Holdings, Inc.. This profile follows SEC Form 4 activity through Aug 5, 2024, including 3 public disclosures. Recent filings connect the profile to Cerevel Therapeutics Holdings, Inc. (CERE). The current snapshot covers public activity from Aug 5, 2024. Reported amounts are shown as $286.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.